Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.35 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL268986 | 0.82 | LMNA (0.36) | NPC1MAPTLMNAATMALDH1A1 | |
| SCHEMBL13270945 | 0.81 | GPR88 (0.43) | GPR88LNPEPNPC1LMNAGAA | |
| SCHEMBL13492209 | 0.81 | LMNA (0.35) | NPC1MAPTLMNASLC6A3ATM | |
| SCHEMBL15298008 | 0.79 | LMNA (0.43) | NPC1MAPTLMNAATMALDH1A1 | |
| SCHEMBL1551245 | 0.78 | LMNA (0.33) | LMNAALDH1A1HRH3 | |
| SCHEMBL13658284 | 0.78 | NPC1 (0.55) | NPC1MAPTLMNASLC6A3ALDH1A1 | |
| SCHEMBL1704092 | 0.76 | LMNA (0.35) | NPC1MAPTLMNAALDH1A1TDP1 | |
| SCHEMBL4023346 | 0.75 | ESR1 (0.41) | NPC1MAPTLMNAALDH1A1HTT | |
| SCHEMBL13299343 | 0.75 | NPC1 (0.46) | NPC1MAPTLMNACRHR1GAA | |
| SCHEMBL10253638 | 0.74 | CNR1 (0.36) | GPR88LNPEPNPC1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040234559-A1 | Self foaming or mousse-type preparations comprising organic hydrocolloids and particulate hydrophobic and/or hydrophobed and/or oil-absorbing solid substances | BEIERSDORF AG (DE) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040234559-A1 | Self foaming or mousse-type preparations comprising organic hydrocolloids and particulate hydrophobic and/or hydrophobed and/or oil-absorbing solid substances | HAO2, LIPA, FABP4 | GPR88 667/4885LNPEP 2836/4885NPC1 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.